Prolonged siRNA expression in mammalian cells using an Epstein-Barr virus-based plasmid expression system

Area of Science:

• Molecular Biology
• Gene Therapy
• Virology

Background:

• RNA interference (RNAi) is valuable for gene analysis and treating diseases, but its application is hindered by short duration and toxicity.
• Epstein-Barr virus nuclear antigen 1 (EBNA-1) and origin of plasmid replication (oriP) facilitate long-term extrachromosomal maintenance of the EBV genome.

Purpose of the Study:

• To develop a novel plasmid expression system for sustained production of proteins and short interfering RNAs (siRNAs) in mammalian cells.
• To leverage EBNA-1 and oriP for long-term gene silencing and protein expression.

Main Methods:

• Constructed a plasmid expression system utilizing EBNA-1 and oriP.
• Introduced the system into mammalian cells for evaluating protein and siRNA production.
• Assessed the efficiency and specificity of gene down-regulation mediated by the expressed siRNAs.

Main Results:

• The EBNA-1/oriP-based system achieved prolonged protein and siRNA expression in mammalian cells.
• siRNA expression effectively and specifically downregulated target gene expression.
• The system demonstrated potential for long-term therapeutic applications.

Conclusions:

• The developed plasmid system offers a robust platform for sustained gene silencing and protein production.
• This approach provides a promising strategy for enhancing RNAi-based therapies requiring enduring effects.
• The system is applicable for both gene function analysis and potential therapeutic interventions.